Literature DB >> 2579716

Reanalysis of the RTOG study of the palliation of symptomatic osseous metastasis.

P H Blitzer.   

Abstract

This is a reanalysis of the data from the Radiation Therapy Oncology Group (RTOG) study of the palliation of metastasis to bone. The RTOG multicenter clinical trial studied pain relief in 759 patients randomly assigned to a variety of dose-fractionation schedules: 270 cGy X 15 fractions, 300 X 10, 300 X 5,400 X 5, and 500 X 5. The multivariate statistical technique of logistic regression was used. The results differed from a previous report in that number of fractions was statistically significantly related to complete combined relief (that is, absence of pain and cessation of the use of narcotics). Also, the time dose factor (TDF) isoeffect conversion did not accurately predict tumor response. The conclusion is that protracted dose-fractionation schedules are more effective than short course schedules.

Entities:  

Mesh:

Year:  1985        PMID: 2579716     DOI: 10.1002/1097-0142(19850401)55:7<1468::aid-cncr2820550708>3.0.co;2-m

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  20 in total

1.  Prostate cancer: 10. Palliative care.

Authors:  N A Iscoe; E Bruera; R C Choo
Journal:  CMAJ       Date:  1999-02-09       Impact factor: 8.262

Review 2.  WITHDRAWN: Radiotherapy for the palliation of painful bone metastases.

Authors:  Henry J McQuay; Sally L Collins; Dawn Carroll; R Andrew Moore; Sheena Derry
Journal:  Cochrane Database Syst Rev       Date:  2013-11-22

Review 3.  The use of radiation in the management of spinal metastases.

Authors:  C M Faul; J C Flickinger
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

Review 4.  Causes and treatment of bone pain of malignant origin.

Authors:  B Thürlimann; N D de Stoutz
Journal:  Drugs       Date:  1996-03       Impact factor: 9.546

5.  European French-speaking study from the GEMO group on bone metastases management: a special focus on external beam radiotherapy practice survey.

Authors:  Nicolas Magné; Cyrus Chargari; René Olivier Mirimanoff; Pierre Olivier; Jean Philippe Vuillez; Michèle Tubiana-Hulin; Jean Jacques Body; Jean Léon Lagrange
Journal:  Support Care Cancer       Date:  2010-08-31       Impact factor: 3.603

Review 6.  Radiotherapeutic approaches to metastatic disease.

Authors:  Edward Chow; Jackson Wu; Andrew Loblaw; Carlos A Perez
Journal:  World J Urol       Date:  2003-08-09       Impact factor: 4.226

Review 7.  The management of painful bone metastases with an emphasis on radionuclide therapy.

Authors:  Darren J Hillegonds; Stephen Franklin; David K Shelton; Srinivasan Vijayakumar; Vani Vijayakumar
Journal:  J Natl Med Assoc       Date:  2007-07       Impact factor: 1.798

8.  Zoledronic acid concurrent with either high- or reduced-dose palliative radiotherapy in the management of the breast cancer patients with bone metastases: a phase IV randomized clinical study.

Authors:  Lale Atahan; Ferah Yildiz; Mustafa Cengiz; Bunyamin Kaplan; Metin Ozkan; Gozde Yazici; Mete Gündoğ; Ayfer Haydaroğlu; Aylin F Korcum; Meriç Sengöz; Maktav Dinçer; Müge Akmansu; Kayihan Engin; Mutlu Hayran
Journal:  Support Care Cancer       Date:  2009-05-31       Impact factor: 3.603

Review 9.  Stereotactic radiosurgery in the management of cancer pain.

Authors:  Marsha Haley; Peter C Gerszten
Journal:  Curr Pain Headache Rep       Date:  2009-08

10.  Percutaneous radiofrequency ablation of painful osseous metastases: a multicenter American College of Radiology Imaging Network trial.

Authors:  Damian E Dupuy; Dawei Liu; Donna Hartfeil; Lucy Hanna; Jeffrey D Blume; Kamran Ahrar; Robert Lopez; Howard Safran; Thomas DiPetrillo
Journal:  Cancer       Date:  2010-02-15       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.